Results 201 to 210 of about 215,700 (362)

Efficacy and safety of holographic scraping in insomnia: A systematic review and meta-analysis of randomized controlled trials. [PDF]

Medicine (Baltimore)
Qi X, Kong H, Li J, Chen C.
europepmc   +1 more source

Restless REM sleep in insomnia disorder and its detrimental effects on regulation of emotional distress

, 2019
P.F. Wassing
openalex   +1 more source

Is lorazepam 0.5 mg an appropriate medication for treating insomnia?

Tripdatabase
openalex   +1 more source

Deep Brain Stimulation and Pregnancy: A Case Report and Literature Review

Movement Disorders Clinical Practice, EarlyView.
Verónica Cabreira, Maria José Rosas
wiley   +1 more source

The effect of Baduanjin on sleep quality in primary insomnia patients: a systematic review and meta-analysis

Ziqiong Chen
openalex   +1 more source

Distinct Symptom Occurrence Subgroups Among Patients With Colorectal Cancer: Differences in Social Determinants of Health and Diet Quality

Research in Nursing &Health, EarlyView.
ABSTRACT Colorectal cancer (CRC) is a leading cause of cancer mortality in the United States. Many patients with CRC experience physical and psychological symptoms that diminish quality of life and are shaped by social determinants of health (SDOH) and diet quality.
Youran Lee, Qing Yang, Melissa Kay, Donald E. Bailey, Biljana Gigic, Sheetal Hardikar, Adetunji T. Toriola, David Shibata, Christopher I. Li, Doratha A. Byrd, Jane C. Figueiredo, Ildiko Strehli, Megan Mclaws, Vaia Florou, Mmadili Ilozumba, Patricia Erickson, Apurva Medhe, Cornelia M. Ulrich, Rosa M. Gonzalez‐Guarda   +18 more
wiley   +1 more source

Patient-Reported Outcomes for LEMborexant Treatment in Chinese Patients with Insomnia (PROEM): A Multicenter, Prospective, Real-World Observational Study. [PDF]

Nat Sci Sleep
Zheng S, Li X, Jian W, Tang Y, Lin Y, Jia F, Zhang B.   +6 more
europepmc   +1 more source

“Comorbid” Insomnia

Indian Journal of Psychological Medicine, 2011
M S Reddy, Arindam Chakrabarty
openaire   +4 more sources

Diurnal‐Only Foslevodopa/Foscarbidopa

Movement Disorders Clinical Practice, EarlyView.
Alexandra McGuckin, Yu‐Yan Poon, Galit Kleiner, Alfonso Fasano   +3 more
wiley   +1 more source

Effectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency

Obesity, EarlyView.
ABSTRACT Setmelanotide, a melanocortin 4 receptor (MC4R) agonist, is a promising pharmacological treatment option for people with rare monogenic obesity conditions affecting the leptin‐melanocortin signaling pathway, including proprotein convertase subtilisin/kexin type 1 (PCSK1) gene mutations.
Ellina Lytvyak, Arshdeep Rattol, Eduardo Grunvald   +2 more
wiley   +1 more source